Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice

Abernathy, 2021, Polylactose exhibits prebiotic activity and reduces adiposity and nonalcoholic fatty liver disease in rats fed a high-fat diet, J. Nutr., 151, 352, 10.1093/jn/nxaa376 Arab, 2017, Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives, Hepatology, 65, 350, 10.1002/hep.28709 Bäckhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl. Acad. Sci. USA, 101, 15718, 10.1073/pnas.0407076101 Behrouz, 2020, Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: a randomized clinical trial, J. Food Sci., 85, 3611, 10.1111/1750-3841.15367 Bellassoued, 2015, Protective effect of kombucha on rats fed a hypercholesterolemic diet is mediated by its antioxidant activity, Pharm. Biol., 53, 1699, 10.3109/13880209.2014.1001408 Bessone, 2019, Molecular pathways of nonalcoholic fatty liver disease development and progression, Cell Mol. Life Sci., 76, 99, 10.1007/s00018-018-2947-0 Boulangé, 2016, Impact of the gut microbiota on inflammation, obesity, and metabolic disease, Genome Med, 8, 1, 10.1186/s13073-016-0303-2 Cani, 2016, How gut microbes talk to organs: The role of endocrine and nervous routes Cano, 2013, Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice, Obes. (Silver Spring), 21, 2310, 10.1002/oby.20330 Carino, 2017, BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis, Sci. Rep., 7, 42801, 10.1038/srep42801 Chavez-Talavera, 2017, Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease, Gastroenterology, 152, 1679, 10.1053/j.gastro.2017.01.055 Chiang, 2013, Bile acid metabolism and signaling, Compr. Physiol., 3, 1191, 10.1002/cphy.c120023 Chunchai, 2018, Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or symbiotics effectively restored cognitive function in obese-insulin resistant rats, J. Neuroinflamm., 15, 11, 10.1186/s12974-018-1055-2 Crabtree, 1972, The activities of phosphorylase, hexokinase, phosphofructokinase, lactate dehydrogenase and the glycerol 3-phosphate dehydrogenases in muscles from vertebrates and invertebrates, Biochem J., 126, 49, 10.1042/bj1260049 Daniel, 2014, High-fat diet alters gut microbiota physiology in mice, ISME J., 8, 295, 10.1038/ismej.2013.155 Dufresne, 2000, Tea, Kombucha, and health: a review, Food Res. Int., 33, 409, 10.1016/S0963-9969(00)00067-3 Dutta, 2016, Men and mice: relating their ages, Life Sci., 152, 244, 10.1016/j.lfs.2015.10.025 Han, 2016, Regulation of glucose metabolism from a liver-centric perspective, Exp. Mol. Med., 48, 10.1038/emm.2015.122 Holmes, 2012, Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk, Cell Metab., 16, 559, 10.1016/j.cmet.2012.10.007 Hove, 2015, Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomized double-blind placebo-controlled study, Eur. J. Endocrinol., 172, 11, 10.1530/EJE-14-0554 Hoyles, 2018, Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women, Nat. Med., 24, 1070, 10.1038/s41591-018-0061-3 Hyun, 2016, Kombucha tea prevents obese mice from developing hepatic steatosis and liver damage, Food Sci. Biotechnol., 25, 861, 10.1007/s10068-016-0142-3 Jung, 2019, Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease, Food Sci. Biotechnol., 28, 261, 10.1007/s10068-018-0433-y Kapp, 2019, Kombucha: a systematic review of the empirical evidence of human health benefit, Ann. Epidemiol., 30, 66, 10.1016/j.annepidem.2018.11.001 Kobyliak, 2018, A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial, J. Gastrointestin Liver Dis., Vol. 27, 41, 10.15403/jgld.2014.1121.271.kby Lakhani, 2008, Small intestinal bacterial overgrowth, and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients, Nutr. Res., 28, 293, 10.1016/j.nutres.2008.03.002 Leal, 2018, Uma revisão sobre os benefícios para a saúde dos compostos nutricionais e metabólitos do kombuchá, CyTA J. Food, 16, 390 Lenzen, 2014, A fresh view of glycolysis and glucokinase regulation: history and current status, J. Biol. Chem., 289, 12189, 10.1074/jbc.R114.557314 Li, 2011, AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin resistant mice, Cell Metab., 13, 376, 10.1016/j.cmet.2011.03.009 Loomba, 2021, Mechanisms and disease consequences of nonalcoholic fatty liver disease, Cell, 184, 2537, 10.1016/j.cell.2021.04.015 Ma, 2008, Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells, J. Hepatol., 49, 821, 10.1016/j.jhep.2008.05.025 Madrid, 2011, Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients, Dig. Dis. Sci., 56, 155, 10.1007/s10620-010-1239-9 Marçal, 2013, Changes in food intake, metabolic parameters and insulin resistance are induced by an isoenergetic, medium-chain fatty acid diet and are associated with modifications in insulin signalling in isolated rat pancreatic islets, Br. J. Nutr., 109, 2154, 10.1017/S0007114512004576 Nagpal, 2018, Obesity-linked gut microbiome dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet, J. Diabetes Res., 2018, 10.1155/2018/3462092 Opie, 1967, The activities of fructose 1,6-diphosphatase, phosphofructokinase, and phosphoenolpyruvate carboxykinase in white muscle and red muscle, Chem. J., 103, 391 Shin, 2010, Hypocholesterolemiceffect of sonication-killed Bifidobacterium longum isolated from healthy adult Koreans in high cholesterol fed rats, Arch. Pharm. Res, 33, 1425, 10.1007/s12272-010-0917-7 Soares, 2010, The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases, Hepatol. Int, 4, 659, 10.1007/s12072-010-9219-x Stefan, 2018, Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies, Lancet Diabetes Endocrinol., 18 Tagliari, 2017, The impact of the use of symbiotics in the progression of nonalcoholic fatty liver disease in a rat model, Arq. Bras. Cir. Dig., 30, 211, 10.1590/0102-6720201700030011 Thiennimitr, 2018, Lactobacillus paracasei HII01, oligosaccharides and symbiotic reduced gut disturbance 1 in obese rats, Nutrition, 10.1016/j.nut.2018.03.005 Tilg, 2016, Gut microbiome and liver diseases, Gut, 65, 2035, 10.1136/gutjnl-2016-312729 Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharm. Ther., 34, 274, 10.1111/j.1365-2036.2011.04724.x Wang, 2014, Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components, J. Sci. Food Agric., 94, 265, 10.1002/jsfa.6245 Wong, 2013, Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study, Ann. Hepatol., 12, 256, 10.1016/S1665-2681(19)31364-X Wu, 2019, Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis, Gut, 68, 248, 10.1136/gutjnl-2017-315458 Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease—metanalytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Zammit, 1978, Properties of pyruvate kinase and phosphoenolpyruvate carboxykinase in relation to the direction and regulation of phosphoenolpyruvate metabolism in muscles of the frog and marine invertebrates, Biochem. J., 174, 979, 10.1042/bj1740979